Pediatrics Doctors in Spokane, WA Accepting Medicare
112 Pediatrics doctors found. Showing 1 - 20
 Robert E Piston, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6002 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-4402 Fax: 509-483-7631 |
 Dr. Tanisha Kamille Morton, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 6002 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-4402 |
Sarah E D'hulst, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 400 E 5th Ave, Spokane, WA 99202 Phone: 509-838-2531 |
Dr. Joseph Paul Kincaid, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 408 W 25th Ave, Spokane, WA 99203 Phone: 509-999-8237 |
Carrie Elizabeth Laborde, M.D. Pediatrics - Pediatric Hematology-Oncology Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave Fl 3, Spokane, WA 99204 Phone: 509-474-2777 Fax: 509-474-6222 |
Dr. David Ross Goshorn, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Pshmc 3rd Flr, Spokane, WA 99204 Phone: 509-474-2277 |
Dr. Ronda Jean Gretebeck, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 35 W 8th Ave, Spokane, WA 99204 Phone: 509-456-6556 Fax: 509-455-8801 |
Jennifer A Troiano, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-2730 Fax: 509-462-4086 |
Dr. Jennifer L Kalisvaart, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 315 W 9th Ave Ste 200, Spokane, WA 99204 Phone: 509-960-8894 Fax: 509-290-6820 |
Carl Puzant Garabedian, MD Pediatrics - Pediatric Cardiology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave, Suite 4300, Spokane, WA 99204 Phone: 509-747-6707 Fax: 509-624-9186 |
Dr. Julie Rebecca Kaswick, M.D. Pediatrics - Pediatric Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-3131 |
Ashlee Diane Mickelson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3919 N Maple St, Spokane, WA 99205 Phone: 509-444-8888 Fax: 509-444-7806 |
Dr. Ronald Shapiro, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Not Enrolled in Medicare Practice Location: 35 W 8th Ave, Spokane, WA 99204 Phone: 509-456-6556 Fax: 509-455-8801 |
Dr. Matthew A Thompson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 319 W 8th Ave, Spokane, WA 99204 Phone: 509-448-7337 Fax: 509-448-4750 |
Michael Donlan, M.D. Pediatrics - Adolescent Medicine Medicare: Not Enrolled in Medicare Practice Location: 7103 N Skyline Dr, Spokane, WA 99208 Phone: 509-326-9510 |
April R Jaeger, MD Pediatrics - Pediatric Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99204 Phone: 509-474-4599 Fax: 509-474-5695 |
Dr. Erik Lee Strandness, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 35 W 8th Ave, Spokane, WA 99204 Phone: 509-456-6556 |
Renata Milena Stoszek Moon, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 322 W North River Dr, Spokane, WA 99201 Phone: 509-324-6464 |
Dr. Elizabeth Ann Tomeo, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5921 N Market St, Spokane, WA 99208 Phone: 509-487-1604 Fax: 509-482-6286 |
Dr. Bridget Thompson, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 101 W 8th Ave Ste 4200, Spokane, WA 99204 Phone: 509-474-5440 Fax: 509-227-7070 |
News Archive
OraSure granted FDA approval for final phase studies of OraQuick Rapid HIV-1/2 Antibody Test
OraSure Technologies, Inc., the market leader in oral fluid diagnostics, today announced that the U.S. Food and Drug Administration ("FDA") has granted an investigational device exemption (IDE) for the Company to conduct the final phase of clinical testing for FDA approval of its OraQuick® Rapid HIV-1/2 Antibody Test for sale in the consumer or over-the-counter ("OTC") market.
Neighboring non-cancer cells may contribute to drug resistance
One of cancer's most frightening characteristics is its ability to return after treatment. In the case of many forms of cancer, including the skin cancer known as melanoma, tailored drugs can eradicate cancer cells in the lab, but often produce only partial, temporary responses in patients. One of the burning questions in the field of cancer research has been and remains: how does cancer evade drug treatment?
Brookhaven target compounds to fight SARS
Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have set the stage for the rapid identification of compounds to fight against severe acquired respiratory syndrome (SARS), the atypical pneumonia responsible for about 800 deaths worldwide since first recognized in late 2002.
Omecamtiv mecarbil fails to achieve primary endpoint in phase II ATOMIC-AHF study
Omecamtiv mecarbil, a cardiac myosin-activator, did not achieve its primary efficacy endpoint in reducing dyspnoea (shortness of breath) in patients with acute heart failure, according to the results of the phase II ATOMIC-AHF (Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure) study.
› Verified 5 days ago
Internal Medicine
Family Medicine
Psychiatry & Neurology
Anesthesiology
Radiology
Pediatrics
Emergency Medicine
Surgery
Obstetrics & Gynecology
Orthopaedic Surgery